Literature DB >> 2390665

High-frequency chest compression system to aid in clearance of mucus from the lung.

L G Hansen1, W J Warwick.   

Abstract

The authors developed a high-frequency chest compression (HFCC) device to aid in mucous clearance for patients with obstructive lung disease. The device, designed for self-therapy, consists of a large-volume variable-frequency air-pulse delivery system and a nonstretchable inflatable vest worn by the patient. Pressure pulses are controlled by the patient and applied during expiration. Pulse frequency is tunable from 5 to 25 Hz. Maximum vest pressure is 39 mmHg (5.2 kPa), with patient-controlled vest inflation and deflation time constants of 0.5 s. Vest pressure increases from 28 mmHg (3.7 kPa) at 5 Hz to 39 mmHg (5.2 kPa) at 25 Hz. Preliminary clinical trials have shown the HFCC device to be more effective than standard chest physical therapy. The HFCC device yielded a mean volume of cleared mucus of 3.3 cc per session, compared with 1.8 cc for a conventional therapy session.

Entities:  

Mesh:

Year:  1990        PMID: 2390665

Source DB:  PubMed          Journal:  Biomed Instrum Technol        ISSN: 0899-8205


  13 in total

1.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Milroy
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

Review 2.  Structure and function of the mucus clearance system of the lung.

Authors:  Brenda M Button; Brian Button
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

Review 3.  Oscillating devices for airway clearance in people with cystic fibrosis.

Authors:  Lisa Morrison; Stephanie Innes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-04

4.  Airway clearance devices for cystic fibrosis: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

5.  High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial.

Authors:  Amit K Mahajan; Gregory B Diette; Umur Hatipoğlu; Andrew Bilderback; Alana Ridge; Vanessa Walker Harris; Vijay Dalapathi; Sameer Badlani; Stephanie Lewis; Jeff T Charbeneau; Edward T Naureckas; Jerry A Krishnan
Journal:  Respir Res       Date:  2011-09-10

6.  Short-term effects of high-frequency chest compression and positive expiratory pressure in patients with cystic fibrosis.

Authors:  Valentina Fainardi; Francesco Longo; Silvia Faverzani; Maria Candida Tripodi; Alfredo Chetta; Giovanna Pisi
Journal:  J Clin Med Res       Date:  2011-11-10

7.  Physiotherapy Intervention During Level I of Pulmonary Rehabilitation on Chronic Obstructive Pulmonary Disease: A Systematic Review.

Authors:  Guilherme Medeiros de Alvarenga; Humberto Remigio Gamba; Lilian Elisa Hellman; Vanusa Ganzert Ferrari; Rafael Michel de Macedo
Journal:  Open Respir Med J       Date:  2016-02-29

8.  Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis.

Authors:  Leyla P Osman; Michael Roughton; Margaret E Hodson; Jennifer A Pryor
Journal:  Thorax       Date:  2009-08-23       Impact factor: 9.139

9.  Evaluation of the safety of high-frequency chest wall oscillation (HFCWO) therapy in blunt thoracic trauma patients.

Authors:  Casandra A Anderson; Cassandra A Palmer; Arthur L Ney; Brian Becker; Robert R Quickel; Steven D Schaffel
Journal:  J Trauma Manag Outcomes       Date:  2008-10-06

10.  Vest Chest Physiotherapy Airway Clearance is Associated with Nitric Oxide Metabolism.

Authors:  Joseph H Sisson; Todd A Wyatt; Jacqueline A Pavlik; Pawanjit S Sarna; Peter J Murphy
Journal:  Pulm Med       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.